Sangamo BioSciences (SGMO) BidaskScore is lowered to Bought

Sangamo BioSciences

The BidaskScore of Sangamo BioSciences SGMOSGMO shows that the shares of the company are now SGMOStrongly Bought Bought by investors.

The BidaskScore of the BiotechnologyBiotechnology shows that the sector is BiotechnologyStrongly Bought Held since September 5.

Here are the BidAskScore of other related companies in the Biotechnology sector:

Sangamo Therapeuticsˌ Inc. researches and develops transcription factors in the regulation of genes. It focuses on the researchˌ development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering of a class of transcription factors known as zinc finger DNA-binding proteins. The company was founded by Lanphier O. Edward II on June 22ˌ 1995 and is headquartered in Richmondˌ CA.

Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.